Skip to Content

435 (Acamprosate Calcium Delayed-Release 333 mg)

Pill with imprint 435 is White, Round and has been identified as Acamprosate Calcium Delayed-Release 333 mg. It is supplied by Glenmark Generics Inc., USA.

Acamprosate is used in the treatment of alcohol dependence and belongs to the drug class drugs used in alcohol dependence. Risk cannot be ruled out during pregnancy. Acamprosate 333 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 435

Acamprosate calcium delayed-release 333 mg 435
Acamprosate calcium delayed-release 333 mg 435 Front
Acamprosate calcium delayed-release 333 mg 435 Back
Acamprosate calcium delayed-release 333 mg 435
Acamprosate calcium delayed-release 333 mg 435

Acamprosate Calcium Delayed-Release

Imprint
435
Strength
333 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Drugs used in alcohol dependence
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Generics Inc., USA

Labelers / Repackagers

NDC Code Labeler / Repackager
68462-0435 Glenmark Pharmaceuticals Inc.
10135-0636 Marlex Pharmaceuticals Inc.

Get help with Imprint Code FAQs.

Related Images for "435"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.